Cargando…
Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
BACKGROUND: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete. AIM:...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384749/ https://www.ncbi.nlm.nih.gov/pubmed/34497449 http://dx.doi.org/10.3748/wjg.v27.i31.5259 |
_version_ | 1783741959778598912 |
---|---|
author | Mashukov, Artem Shapochka, Dmytro Seleznov, Oleksii Kobyliak, Nazarii Falalyeyeva, Tetyana Kirkilevsky, Stanislav Yarema, Roman Sulaieva, Oksana |
author_facet | Mashukov, Artem Shapochka, Dmytro Seleznov, Oleksii Kobyliak, Nazarii Falalyeyeva, Tetyana Kirkilevsky, Stanislav Yarema, Roman Sulaieva, Oksana |
author_sort | Mashukov, Artem |
collection | PubMed |
description | BACKGROUND: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete. AIM: To clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept. METHODS: In total, 50 GC cases were examined (15 cases of diffuse GC, 31 patients with intestinal-type GC and 4 cases of mucinous GC). The immunophenotype of GC was assessed and classified as immune desert (ID), immune excluded (IE) or inflamed (Inf) according to CD8+ cell count and spatial pattern. In addition, CD68+ and CD163+ macrophages and programmed death-ligand 1 (PD-L1) expression were estimated. RESULTS: We found that GCs with different histological differentiation demonstrated distinct immune contexture. Most intestinal-type GCs had inflamed TIMEs rich in both CD8+ cells and macrophages. In contrast, more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+ lymphocytes but abundant CD68+ macrophages, while mucinous GC had an IE-TIME with a prevalence of CD68+ macrophages and CD8+ lymphocytes in the peritumor stroma. PD-L1 expression prevailed mostly in intestinal-type Inf-GC, with numerous CD163+ cells observed. Therefore, GCs of different histological patterns have specific mechanisms of immune escape. While intestinal-type GC was more often related to PD-L1 expression, diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters. CONCLUSION: These data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management. |
format | Online Article Text |
id | pubmed-8384749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-83847492021-09-07 Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle Mashukov, Artem Shapochka, Dmytro Seleznov, Oleksii Kobyliak, Nazarii Falalyeyeva, Tetyana Kirkilevsky, Stanislav Yarema, Roman Sulaieva, Oksana World J Gastroenterol Retrospective Study BACKGROUND: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete. AIM: To clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept. METHODS: In total, 50 GC cases were examined (15 cases of diffuse GC, 31 patients with intestinal-type GC and 4 cases of mucinous GC). The immunophenotype of GC was assessed and classified as immune desert (ID), immune excluded (IE) or inflamed (Inf) according to CD8+ cell count and spatial pattern. In addition, CD68+ and CD163+ macrophages and programmed death-ligand 1 (PD-L1) expression were estimated. RESULTS: We found that GCs with different histological differentiation demonstrated distinct immune contexture. Most intestinal-type GCs had inflamed TIMEs rich in both CD8+ cells and macrophages. In contrast, more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+ lymphocytes but abundant CD68+ macrophages, while mucinous GC had an IE-TIME with a prevalence of CD68+ macrophages and CD8+ lymphocytes in the peritumor stroma. PD-L1 expression prevailed mostly in intestinal-type Inf-GC, with numerous CD163+ cells observed. Therefore, GCs of different histological patterns have specific mechanisms of immune escape. While intestinal-type GC was more often related to PD-L1 expression, diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters. CONCLUSION: These data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management. Baishideng Publishing Group Inc 2021-08-21 2021-08-21 /pmc/articles/PMC8384749/ /pubmed/34497449 http://dx.doi.org/10.3748/wjg.v27.i31.5259 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Retrospective Study Mashukov, Artem Shapochka, Dmytro Seleznov, Oleksii Kobyliak, Nazarii Falalyeyeva, Tetyana Kirkilevsky, Stanislav Yarema, Roman Sulaieva, Oksana Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle |
title | Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle |
title_full | Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle |
title_fullStr | Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle |
title_full_unstemmed | Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle |
title_short | Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle |
title_sort | histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: relation to the immune cycle |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384749/ https://www.ncbi.nlm.nih.gov/pubmed/34497449 http://dx.doi.org/10.3748/wjg.v27.i31.5259 |
work_keys_str_mv | AT mashukovartem histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT shapochkadmytro histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT seleznovoleksii histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT kobyliaknazarii histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT falalyeyevatetyana histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT kirkilevskystanislav histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT yaremaroman histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle AT sulaievaoksana histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle |